MarketCap
Facebook
X
Telegram
Apellis Pharmaceuticals PEG | APLS
PEG Jährlich Apellis Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.4 | 4.07 | -0.516 | -0.361 | - | 0.736 | 0.0775 | -0.159 | 0.0347 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.07 | -5.4 | -0.19 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Cytokinetics, Incorporated
CYTK
|
-0.000001 | $ 54.5 | -14.31 % | $ 6.55 M |  USA |
 |
DiaMedica Therapeutics
DMAC
|
-14 | $ 9.03 | -16.16 % | $ 424 M | USA |
 |
Edesa Biotech
EDSA
|
-0.0227 | $ 2.14 | -1.38 % | $ 12.1 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-0.471 | $ 13.88 | -8.86 % | $ 898 M | USA |
 |
Evogene Ltd.
EVGN
|
-0.00649 | $ 0.32 | -9.87 % | $ 2.52 M |  Israel |
 |
Exelixis
EXEL
|
-2.14 | $ 68.71 | -5.56 % | $ 18.7 B | USA |
 |
Xeris Pharmaceuticals
XERS
|
-26.7 | $ 13.16 | 25.76 % | $ 2.11 B | USA |
 |
Fennec Pharmaceuticals
FENC
|
0.000178 | $ 9.35 | -9.66 % | $ 267 M | USA |
 |
AbbVie
ABBV
|
21.1 | $ 288.16 | -2.26 % | $ 510 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 1.58 | -5.39 % | $ 2.6 M | Israel |
 |
vTv Therapeutics
VTVT
|
-76.9 | $ 21.86 | -9.03 % | $ 86.4 M | USA |
 |
Forte Biosciences
FBRX
|
-0.00934 | $ 76.99 | 0.03 % | $ 997 M | USA |
 |
AC Immune SA
ACIU
|
2.39 | $ 2.11 | -7.86 % | $ 213 M |  Schweiz |
 |
Aldeyra Therapeutics
ALDX
|
1.65 | $ 0.61 | -5.56 % | $ 36.6 M | USA |
 |
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M |  Canada |
 |
AIM ImmunoTech
AIM
|
-0.000094 | $ 0.15 | -4.97 % | $ 243 K | USA |
 |
Ascendis Pharma A/S
ASND
|
4.41 | $ 252.45 | -2.12 % | $ 15.3 B |  Danmark |
 |
ANI Pharmaceuticals
ANIP
|
0.147 | $ 69.63 | -2.83 % | $ 1.4 B | USA |
 |
Actinium Pharmaceuticals
ATNM
|
0.175 | $ 1.31 | -7.09 % | $ 40.9 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.24 | -10.14 % | $ 330 M |  Britain |
 |
BridgeBio Pharma
BBIO
|
2.48 | $ 74.33 | -4.57 % | $ 14.2 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
-0.00258 | $ 7.51 | -8.92 % | $ 1.58 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
-0.167 | $ 3.49 | -6.18 % | $ 242 M | Britain |
 |
Coherus BioSciences
CHRS
|
-0.0207 | $ 0.75 | -11.77 % | $ 87.9 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
6.77 | $ 27.01 | -20.69 % | $ 3.44 B | USA |
 |
Cellectis S.A.
CLLS
|
0.221 | $ 1.01 | -13.68 % | $ 101 M |  France |
 |
BeyondSpring
BYSI
|
2.09 | $ 0.65 | -4.9 % | $ 26.7 M | USA |
 |
Alkermes plc
ALKS
|
-0.493 | $ 44.51 | -3.01 % | $ 7.33 B |  Irlanda |
 |
Altimmune
ALT
|
0.647 | $ 1.97 | -7.31 % | $ 174 M | USA |
 |
Cardiff Oncology
CRDF
|
185 | $ 0.76 | -13.05 % | $ 50.8 M | USA |
 |
Citius Pharmaceuticals
CTXR
|
-0.000437 | $ 0.55 | -0.07 % | $ 6.09 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
0.0261 | $ 9.34 | -14.08 % | $ 256 M | Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
-141 | $ 57.46 | -6.8 % | $ 7.69 B | USA |
 |
Atara Biotherapeutics
ATRA
|
0.00555 | $ 8.04 | -3.94 % | $ 101 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
0.357 | $ 16.17 | -5.49 % | $ 2.17 B | Canada |
 |
BioNTech SE
BNTX
|
0.00586 | $ 85.83 | -5.37 % | $ 20.7 B |  Germany |
 |
Replimune Group
REPL
|
-0.204 | $ 20.15 | -2.61 % | $ 1.87 B | USA |
 |
Collegium Pharmaceutical
COLL
|
0.288 | $ 25.17 | 6.34 % | $ 797 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
-0.0104 | $ 2.84 | -20.45 % | $ 37.8 M | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
-0.041 | $ 1.27 | -8.63 % | $ 58 M | Israel |
 |
AnaptysBio
ANAB
|
0.374 | $ 45.61 | -4.0 % | $ 1.32 B | USA |
 |
Assembly Biosciences
ASMB
|
-0.453 | $ 19.94 | 0.35 % | $ 224 M | USA |
 |
Adagene
ADAG
|
0.612 | $ 2.02 | -16.18 % | $ 119 M |  China |
 |
Benitec Biopharma
BNTC
|
-0.0443 | $ 8.67 | -6.57 % | $ 404 M | USA |
 |
Denali Therapeutics
DNLI
|
0.0634 | $ 19.67 | -6.15 % | $ 3.4 B | USA |
 |
Amarin Corporation plc
AMRN
|
0.633 | $ 11.56 | -5.63 % | $ 4.8 B | Irlanda |
 |
Editas Medicine
EDIT
|
-1.63 | $ 2.53 | -6.99 % | $ 225 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
-0.339 | $ 28.28 | -9.88 % | $ 1.64 B | USA |
 |
Cue Biopharma
CUE
|
0.0442 | $ 18.09 | -8.82 % | $ 1.71 B | USA |